Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C
Information source: Austrian Breast & Colorectal Cancer Study Group
Information obtained from ClinicalTrials.gov on December 31, 2007 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Colon Cancer Stage III
Intervention: 5-fluorouracil, levamisol, interferon (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: Austrian Breast & Colorectal Cancer Study Group Official(s) and/or principal investigator(s): Raimund Jakesz, MD, Principal Investigator, Affiliation: ABCSG
Summary
This clinical investigation examined the effectivity 5-fluorouracil, of adding levamisol or
interferon to 5-fluorouracil, and of a 5-fluorouracil/levamisol/interferon triple
combination, in terms of recurrence-free and overall survival in curatively operable colon
carcinoma Stage III.
Clinical Details
Official title: A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).
Study design: Treatment, Randomized, Open Label, Active Control, Factorial Assignment
Primary outcome: Recurrence-free survivalOverall survival
Eligibility
Minimum age: 18 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
Patients with histologically verified, curatively operated colon carcinoma Stage III (R0,
T1-4, N1-3, M0)
Age: less than 80 years
WHO Performace Status > 2
Adequate bone marrow reserve
Informed consent
Exclusion Criteria:
Rectal cancer
R1, R2, carcinosis peritonei
Start of chemo- or chemo-immunotherapy > 42 days postop; other adjuvant radiotherapy,
chemotherapy or immunotherapy
Serious concomitant disease, in particular chronically inflammatory large intestine,
cardiopathic disease, malignant second carcinoma
Locations and Contacts
Paracelsus Medical University Salzburg - Oncology, Salzburg 5020, Austria
Medical University Vienna, General Hospital, Vienna 1090, Austria
Wilheminenspital, Internal Medicin I, Vienna 1160, Austria
Hospital Guessing, Guessing, Burgenland 7540, Austria
Hospital Oberpullendorf, Oberpullendorf, Burgenland 7350, Austria
Hospital BHB St. Veit/Glan, Surgery, St. Veit a. d. Glan, Carinthia 9330, Austria
State Hospital Wolfsberg, Wolfsberg, Carinthia 9400, Austria
Medical University of Graz, Oncology, Graz, Styria 8036, Austria
State Hospital Leoben, Surgery, Leoben, Styria 8700, Austria
Hospital St. Vinzenz, Zams, Tyrol 6511, Austria
General Hospital Linz, Linz, Upper Austria 4020, Austria
Hospital BHB Linz, Linz, Upper Austria 4020, Austria
Hospital Kreuzschwestern Wels, Wels, Upper Austria 4600, Austria
State Hospital Kirchdorf, Kirchdorf, Upper Austria 4560, Austria
State Hospital Voecklabruck, Internal Medicine, Voecklabruck, Upper Austria 4840, Austria
State Hospital Feldkirch, Feldkirch, Vorarlberg 6807, Austria
Additional Information
Starting date: October 1990
Last updated: March 31, 2006
|